Neurodevelopmental Disorders, Schizophrenia, Bipolar Disorders, Depressive Disorders, Anxiety Disorders, Obsessive-Compulsive Disorders, Eating Disorders, Substance-Related Disorders, Personality Disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (a)Age at registration is between 18 or older and 65 years or younger at the time of enrolment (b)Have a diagnosis of Neurodevelopmental Disorders, Schizophrenia, Bipolar Disorders, Depressive Disorders, Anxiety Disorders, Obsessive-Compulsive Disorders, Eating Disorders, Substance-Related Disorders, Personality Disorder in the DSM-5 of the American Psychiatric Association (c)Have a prescription for psychiatric occupational therapy (d)No plans to change primary medication during the intervention period (e)Total score of 1 or more points on the JSI-mini (Japanese Sensory Inventory mini)
Exclusion criteria
Exclusion criteria: (a)Have cardiac complications (b)Cardiac pacemaker user (c)Have a history of epilepsy (d)Have organic or functional abnormalities of vision, hearing, touch, smell or taste (e)Resistance or fear of confined spaces (f)Risk of harm to others or self-harm (g)Unlikely to complete the study period due to discharge or transfer from hospital (h)Difficulties with participation are envisaged according to the decision of the attending physician (i)Any other history of visual or hearing impairment, language comprehension disorder, mental disorder or motor dysfunction that might interfere with the performance of the tasks of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in resting Respiratory Sinus Arrhythmia (RSA) before and after 30 minutes of intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| [Items Before and After the 30-Minute Intervention] (a) Differences in RSA values in response to sensory stimuli from the Sensory Challenge Protocol (SCP) (b) Differences in scores on the Profile of Mood States 2nd Edition (POMS2) Short Form (c) Differences in scores on the Stanford Sleepiness Scale (SSS) (d) Differences in EEG amplitude (e) Differences in scores on the Multidimensional Assessment of Interoceptive Awareness (MAIA) (f) Differences in heartbeat perception scores [Items During the 30-Minute Intervention] (a) RSA values over 30 minutes (b) Observational records regarding the materials used and behaviors during the intervention [Additional Participant Background Information] (a) Basic demographic information (b) Medical information (c) Scores on the Autism Spectrum Quotient (AQ) | — |
Countries
Japan
Contacts
Kyoto University Department of Human Health Sciences, Graduate School of Medicine